Relationship with ANRF
The Arthritis National Research Foundation is our financial and scientific partner. IBC remains operationally independent, guided by experienced investors, scientists, and healthcare leaders.
A subsidiary of ANRF
Bridging science and capital for better autoimmune outcomes.
Immune Boost Capital is a philanthropic venture fund investing in early, promising autoimmune diagnostics and therapeutics — recycling 100% of returns to fuel the next generation of research.
A philanthropic venture of
The Arthritis National Research Foundation— funding cures since 1970.
501(c)(3)
Our Approach
Strategic capital for early-stage translational science.
A focused model combining scientific partnership, mission-first funding, and recycled returns — built to move promising autoimmune discoveries toward the patients who need them.
Translational Impact
We enable founders and investigators to generate the data needed to attract follow-on venture and strategic investment — accelerating the path from bench to bedside.
Autoimmune Focus
IBC considers investments across the full spectrum of autoimmune conditions, from rare diseases to widespread inflammatory disorders.
Recycled Returns
As an evergreen fund, we reinvest all proceeds from successful investments. Contributions provide immediate donor tax benefits and long-term therapeutic impact.
Translational Impact
From proof-of-concept to patient outcomes.
We fund the critical gap between academic discovery and venture-ready innovation — giving founders and investigators the resources to generate data, validate mechanisms, and attract follow-on capital.
Explore our investment thesis- Stage
- Early translational
- Capital model
- Evergreen & recycled
- Therapeutic area
- Autoimmune, full spectrum
- Partner
- Arthritis National Research Foundation
The team
Meet the full teamOperators and scientists with skin in the game.
Sai Nandi
Founder & Managing Partner
Emily Stormoen
Director of Operations
Jeff Greenberg
Venture Partner
Schalon Newton
Venture Partner
Partner With Us
Help us move autoimmune science forward.
Whether you're a scientist with a breakthrough, a founder building the next therapy, or a donor who believes in compounding impact — there's a place for you at Immune Boost Capital.